Available on the Loop political science blog, April 14 2026
This article examines the emerging bilateral health agreements between the United States and African countries, focusing on provisions concerning health data, pathogen samples, and access to digital health systems. It argues that although these agreements provide important financial support for disease control, health-system strengthening, and pandemic preparedness, they may reproduce unequal relationships between donor and recipient countries. The article conceptualises health and genomic data as increasingly valuable strategic assets and highlights the risk of digital extraction when African countries provide access to data without receiving proportional benefits from its downstream use in pharmaceutical research, artificial intelligence, biotechnology, and other forms of innovation. It argues for a more equitable model of global health cooperation based on data sovereignty, reciprocal benefit sharing, clear rules governing secondary and commercial use, and greater investment in African digital and scientific capacity.